Amgen opened a new research and development site in San Francisco Bay, which will be used to discover new therapeutics for cancer, inflammatory disease and cardiometabolic disorders, the company announced Thursday.
https://www.pharmalive.com/wp-content/uploads/2020/03/Amgen-No-Significant-Delays-COVID-19-Pandemic-KRAS-Inhibitor-BioSpace-3-31-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-10-07 11:44:172022-10-07 11:44:17Amgen, Enzo BioChem and Amphista Therapeutics open new facilities